Showing results (671-680 of 1,531) with videos related to

Sort By:
Pageof 154
The Journal of Pharmacology and Experimental Therapeutics|March 17, 2010
Reduction of L-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's diseaseTom H Johnston, Susan H Fox, Matthew J McIldowie, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 1, 1975
Variability of polymorphic cellular enzymes in medical students with different serum lipid levels: a preliminary surveyM H Fox, H C Dessauer, S R Srinivasan, et al.
The Journal of Biological Chemistry|November 7, 1998
Involvement of the N-finger in the self-association of GATA-1J P Mackay, K Kowalski, A H Fox, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|March 1, 1997
Relationship between human immunodeficiency virus-1 RNA identification in placenta and perinatal transmissionJ M Katz, C H Fox, G S Eglinton, et al.
Journal of the American Board of Family Medicine : JABFM|September 11, 2015
Chronic Kidney Disease Guideline Implementation in Primary Care: A Qualitative Report from the TRANSLATE CKD StudyBonnie M Vest, Trevor R M York, Jessica Sand, et al.
Plos One|November 18, 2014
Trends in extinction risk for imperiled species in CanadaBrett Favaro, Danielle C Claar, Caroline H Fox, et al.
Biochemistry|January 10, 1989
Human T-lymphoblast deoxycytidine kinase: purification and propertiesN S Datta, D S Shewach, M C Hurley, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|January 16, 2018
Botulinum Toxin Type A for Pain in Advanced Parkinson's DiseaseVeronica Bruno, Maria Eliza Freitas, Deborah Mancini, et al.
Heliyon|March 22, 2021
Comparison of multiplex cytokine assays in a pediatric cohort with epilepsyAdam L Numis, Christine H Fox, Daniel J Lowenstein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1996
A randomised trial investigating the dose intensity of primary chemotherapy in patients with ovarian carcinoma: a comparison of chemotherapy given every four weeks with the same chemotherapy given at three week intervalsE Wrigley, A Weaver, G Jayson, et al.
Pageof 154